WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-043,165$18.22
$57.67kSell
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-0442,500$4.82
$204.85kBuy
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-0442,500$15.07
$640.48kSell
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-04147$15.51
$2.28kSell
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-04232$16.38
$3.80kSell
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-045,351$17.74
$94.93kSell
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-0610,875$11.50
$125.06kBuy
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-068,750$10.15
$88.81kBuy
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-0619,625$21.50
$421.94kSell
Eric Blasius RisserChief Operating Officer2024-03-0426,159$19.63
$513.50kSell

1 of 4

MGNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bellevue Group Ag15.94%9,953,313$156.27MInstitution
Target N. V. Biotech15.91%9,929,963$155.90MInsider
Blackrock Inc9.84%6,140,349$96.40MInstitution
T Rowe Price Investment Management Inc9.03%5,639,994$88.55MInstitution
Armistice Capital LLC7.32%4,572,000$71.78MInstitution
Vanguard Group Inc6.90%4,309,394$67.66MInstitution
Ra Capital Management LP6.49%4,053,077$63.63MInstitution
Frazier Life Sciences Management LP3.85%2,401,704$37.71MInstitution
Tpg Group Holdings Sbs Advisors Inc3.54%2,208,762$34.68MInsider
State Street Corp3.48%2,174,022$34.13MInstitution

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX72.54%27.46%Net BuyingNet Selling
CNTA71.06%14.21%Net SellingNet Selling
MDXG42.42%57.58%Net BuyingNet Selling
BCRX83.05%16.95%Net SellingNet Selling
SLN17.28%0.00%
View Top Biotech Stocks

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 99.06% institutional shareholders, 37.51% Macrogenics insiders, and 0.00% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.91% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $142.69M.

If you're new to stock investing, here's how to buy Macrogenics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.